Smith & Nephew PLC (SNN)
25.04
-0.17
(-0.67%)
USD |
NYSE |
Nov 21, 16:00
25.12
+0.08
(+0.32%)
Pre-Market: 20:00
Smith & Nephew 1 Year Total Returns (Daily): 0.93% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | 0.93% |
November 20, 2024 | 1.41% |
November 19, 2024 | 2.42% |
November 18, 2024 | 2.54% |
November 15, 2024 | -0.34% |
November 14, 2024 | -1.57% |
November 13, 2024 | 1.62% |
November 12, 2024 | 3.15% |
November 11, 2024 | 3.83% |
November 08, 2024 | 2.06% |
November 07, 2024 | 5.25% |
November 06, 2024 | 4.05% |
November 05, 2024 | 9.18% |
November 04, 2024 | 7.99% |
November 01, 2024 | 16.32% |
October 31, 2024 | 16.04% |
October 30, 2024 | 34.95% |
October 29, 2024 | 37.23% |
October 28, 2024 | 37.13% |
October 25, 2024 | 33.19% |
October 24, 2024 | 36.50% |
October 23, 2024 | 34.83% |
October 22, 2024 | 35.07% |
October 21, 2024 | 34.75% |
October 18, 2024 | 34.84% |
Date | Value |
---|---|
October 17, 2024 | 31.83% |
October 16, 2024 | 27.85% |
October 15, 2024 | 27.99% |
October 14, 2024 | 28.67% |
October 11, 2024 | 26.40% |
October 10, 2024 | 22.52% |
October 09, 2024 | 24.92% |
October 08, 2024 | 23.56% |
October 07, 2024 | 25.00% |
October 04, 2024 | 31.42% |
October 03, 2024 | 30.79% |
October 02, 2024 | 30.06% |
October 01, 2024 | 28.40% |
September 30, 2024 | 29.65% |
September 27, 2024 | 31.91% |
September 26, 2024 | 26.75% |
September 25, 2024 | 24.02% |
September 24, 2024 | 24.23% |
September 23, 2024 | 24.68% |
September 20, 2024 | 22.20% |
September 19, 2024 | 23.33% |
September 18, 2024 | 21.30% |
September 17, 2024 | 21.40% |
September 16, 2024 | 23.56% |
September 13, 2024 | 22.17% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-38.63%
Minimum
Sep 27 2022
41.27%
Maximum
Mar 18 2021
-4.56%
Average
-5.86%
Median
1 Year Total Returns (Daily) Benchmarks
Haleon PLC | 16.88% |
Adaptimmune Therapeutics PLC | 44.19% |
Biodexa Pharmaceuticals PLC | -93.69% |
Verona Pharma PLC | 163.8% |
NuCana PLC | -87.61% |